Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Submit Guest Post

Pharmacy First has expanded…but where are the pharmacies to deliver it?

"I cannot help feeling that this latest development is another example of good intentions that have not been fully thought through"

Pharmacy First

Jeremy Meader, Chief Wholesale Officer at Bestway Healthcare

Jeremy Meader

The latest expansion of Pharmacy First took a significant step forward at the end of October, when new prescribing arrangements came into effect for five additional clinical pathways, covering conditions including acne, migraine, scabies, mild skin and soft tissue infections, outer ear infections and seasonal allergic rhinitis.

It should have been another significant milestone for community pharmacy. But while the new arrangements are now in place, only a small number of pharmacies are expected to be able to offer the additional services initially.


That raises a fairly fundamental question. What is the point of expanding Pharmacy First if patients cannot access the additional treatments?

I have long been a supporter of Pharmacy First and the opportunities it creates for community pharmacy to play a greater role in primary care. The ambition is absolutely right. Giving patients more opportunities to access treatment through their local pharmacist, while freeing up GP appointments for those who need them most, makes complete sense.

But I cannot help feeling that this latest development is another example of good intentions that have not been fully thought through. The problem is not what pharmacists are being asked to do. It is whether the profession has been given the resources and support to deliver it.

I cannot help feeling that this latest development is another example of good intentions that have not been fully thought through

When Pharmacy First launched in 2024, it covered seven common conditions, with pharmacists able to assess patients and supply appropriate treatment under established clinical pathways.

The latest five conditions operate differently. They require an independent prescriber, and pharmacies must meet additional requirements before they can offer the new pathways. That is a significant distinction.

While thousands of pharmacies already provide Pharmacy First, the number currently equipped to offer independent prescribing services is much smaller.

According to NHS England’s 2025 workforce survey, there was approximately one community pharmacist independent prescriber for every five pharmacy premises in England. And having a qualified prescriber does not automatically mean a pharmacy is authorised and equipped to deliver the new services.

Pharmacy owners must meet additional requirements, including having access to an independent prescriber for at least 24 hours a week across a minimum of 45 weeks each year.

They also need suitable prescribing systems, clinical governance arrangements and NHS approval before they can begin offering the service. These are important safeguards, but they also demonstrate why expanding access will take time and investment.

In the meantime, we risk creating a situation where patients hear that their local pharmacy can now treat a wider range of conditions, only to discover that the particular branch they visit cannot provide the treatment they need.

They may then have to find another participating pharmacy or return to their GP, adding another step to a journey that was supposed to become simpler.

The last thing we need is to undermine growing public confidence by creating expectations that much of the sector cannot yet meet

That is frustrating for patients, but it also risks doing pharmacy a disservice. We have spent years making the case that community pharmacy should be the first point of contact for more everyday healthcare needs. Pharmacy First is beginning to make that ambition a reality.

The last thing we need is to undermine growing public confidence by creating expectations that much of the sector cannot yet meet.

And this is where I believe the Government needs to take a more joined-up approach. There has been investment in preparing for independent prescribing, but is it sufficient to ensure these additional services can be delivered at the scale required?

It is one thing to announce that more conditions can be treated through pharmacy. It is quite another to ensure there are enough qualified professionals, appropriate systems and sufficient financial support to provide that care consistently.

Public awareness is another important consideration. Patients need to understand not only what Pharmacy First offers, but where they can access the different services. Without effective communication, we risk adding confusion to a system that is supposed to make healthcare easier to navigate.

We cannot simply wait for the workforce to catch up and expect everything else to fall into place

There is some good news on the horizon. From September, newly qualified pharmacists have been entering the profession as independent prescribers, representing a major step forward in how we develop and use their clinical skills. Over time, that should significantly increase the number of pharmacies able to provide prescribing services. But it will not happen overnight.

Existing pharmacists will need opportunities to gain the necessary qualifications, while contractors must have the resources to establish and maintain the services.

We cannot simply wait for the workforce to catch up and expect everything else to fall into place.

There is also a wider question about whether we are being ambitious enough. The original seven Pharmacy First conditions were an important starting point, but some account for a relatively small proportion of the consultations that could potentially be managed in community pharmacy.

If the ultimate objective is to free up GP appointments for patients with more complex needs, we need a service that is sufficiently comprehensive and widely available to make a meaningful difference.

Adding five more conditions is welcome, but it should be part of a much bigger plan.

The NHS wants to move more care out of hospitals and into communities. Pharmacy should be central to that ambition, but it needs the infrastructure and investment to make it happen.

Adding five more conditions is welcome, but it should be part of a much bigger plan

I remain a strong supporter of Pharmacy First. It has the potential to transform how patients access everyday healthcare and make much better use of the skills available across community pharmacy. But if we want the public to embrace it, the experience needs to match the promise.

The Government has taken another step in the right direction. Now it needs to make sure the rest of the system can keep up. Because announcing more services is not the same as making them available.

And unless we get that right, we risk falling short of what Pharmacy First could genuinely achieve.